Watch CNBC's full interview with Fidelity's Jurrien Timmer and Trivariate founder Adam Parker

Fidelity Investments’ Jurrien Timmer and Adam Parker, Trivariate Research founder and CEO, join 'Squawk on the Street' to discuss current market trends, why Parker believes the biotech space is oversold and which sector is a good short opportunity.